Argus
•
Apr 29, 2026
GKOS: Lowering target price to $126.00
Summary
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the trea
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Daily – Vickers Top Buyers & Sellers for 04/29/2026
Apr 29, 2026
•
BLK, WULF, ABT, VMI, MSCI, LW, CHTR, NBP, ELF
STAA: Raising target price to $28.00
Apr 29, 2026
•
STAA
PEN: Lowering target price to $359.00
Apr 29, 2026
•
PEN
NEO: Raising target price to $8.00
Apr 29, 2026
•
NEO
GMED: Lowering target price to $100.00
Apr 29, 2026
•
GMED
